venBio Partners LLC
CIK 1776382
13F filing for Q2 2026・No. 3,807
- Holdings
- US$519.38M
- Quarter change
- +US$238.83M
- Entries
- 7
- Net bought (estimate)
- +US$178.87M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 2
- Sold out 1
- Cut 1
- Added 1
- Corporate actions 0
- Unchanged 3
Largest holdings
7 stocks worth US$519.38M, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| PHARVARIS N VCOM | Added | 4,643,430 | US$160.57M | 30.92% |
| PARABILIS MEDICINES INCCOM | New | 5,266,697 | US$144.15M | 27.75% |
| ALUMIS INCCOM | Unchanged | 4,528,408 | US$127.43M | 24.53% |
| ACHIEVE LIFE SCIENCE INCCOM | New | 5,914,720 | US$38.62M | 7.44% |
| ALX ONCOLOGY HLDGS INCCOM | Unchanged | 12,884,638 | US$26.67M | 5.14% |
| HRMYHARMONY BIOSCIENCES HLDGS INCOM | Cut | 472,194 | US$17.19M | 3.31% |
| LYELL IMMUNOPHARMA INCCOM NEW | Unchanged | 337,697 | US$4.74M | 0.91% |
Sign in (free) to see its 7 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.